Key result
Occupational exposure to sevoflurane during cardiopulmonary bypass remained consistently below the recommended target value of 4.68 ppm across all measurement sites.
Why the study?
Does the use of sevoflurane during cardiopulmonary bypass cause occupational exposure exceeding recommended safety limits?
Observational (n=22)
Does the use of sevoflurane during cardiopulmonary bypass cause occupational exposure exceeding recommended safety limits?
Occupational exposure to sevoflurane during cardiopulmonary bypass remains below recommended safety limits when adequate operating room ventilation and waste gas scavenging are utilized.
Supports occupational safety of sevoflurane in CPB with standard scavenging; leaves open need for prospective multi-center confirmation.
Volatile anaesthetic agents are widely used for maintenance of anaesthesia in all kinds of surgical procedures. Despite the implementation of measures such as adequate ventilation of the operating room and the use of efficient scavenging systems, concern remains about the risks for occupational exposure, especially in situations associated with an increased risk of anaesthetic gas waste, such as with the use of volatile anaesthetic agents on cardiopulmonary bypass. The present contribution reports the results of a preliminary safety assessment involving measurements of sevoflurane concentrations in the ambient air of a cardiac surgery operating room. In 22 cardiac surgical procedures with cardiopulmonary bypass (11 with open and 11 with closed venous reservoir), measurements of trace concentrations were obtained every 10 min at the following sites: at the outlet of the oxygenator, at the outlet of the cardiotomy reservoir, in the breathing zone of the perfusionist and above the surgical field. The concentrations were measured on-line using a photoacoustic infrared spectrometer. Mean sevoflurane waste concentrations remained consistently below the recommended target value of 4.68 ppm throughout the observation period at the different measurement sites. These results indicate that, with the use of sevoflurane on cardiopulmonary bypass, the recommended levels for occupational exposure are not exceeded, provided adequate operation room ventilation and waste gas scavenging is performed.
No takes yet. Share an insight, caveat, or question.
Blokker–Veldhuis et al. (2011) conducted an observational in Cardiac surgery with cardiopulmonary bypass (n=22). Sevoflurane was evaluated on Mean sevoflurane waste concentrations in ambient air. Occupational exposure to sevoflurane during cardiopulmonary bypass remained consistently below the recommended target value of 4.68 ppm across all measurement sites.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: